China’s ‘landmark’ drug pricing guidelines widen biotech profit window: analysts
The State Council, China’s cabinet, has published guidelines on innovative drug pricing that a bank analyst has described…
China’s healthcare sector sees record US$10.6 billion fundraising as biotech booms
China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand…